Literature DB >> 2246687

Late-onset ornithine transcarbamylase deficiency in male patients.

J E Finkelstein1, E R Hauser, C O Leonard, S W Brusilow.   

Abstract

We report on 21 male patients who presented after 28 days of age with ornithine transcarbamylase (OTC) deficiency, which we define as late-onset OTC deficiency. These patients appeared normal at birth, but irritability, vomiting, and lethargy, which were often episodic, later developed. The age at presentation ranged from 2 months to 44 years. Biochemical testing revealed hyperammonemia, hyperglutaminemia, hypocitrullinemia, increased urinary orotate excretion, and decreased liver OTC activity measured in vitro, which ranged from 0% to 15% of normal. Male patients who were older at presentation had a somewhat different pattern of presenting symptoms and were more likely to die. These data illustrate the phenotypic variability of OTC deficiency. Unexplained episodes of repetitive or protracted vomiting in association with progressive alterations in behavior or neurologic findings should suggest the diagnosis of a urea cycle defect (or another symptomatic inborn error of metabolism), regardless of the age or medical history of the patient.

Entities:  

Mesh:

Year:  1990        PMID: 2246687     DOI: 10.1016/s0022-3476(05)80129-5

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  22 in total

Review 1.  Ornithine carbamoyltransferase deficiency.

Authors:  J E Wraith
Journal:  Arch Dis Child       Date:  2001-01       Impact factor: 3.791

Review 2.  Young onset dementia.

Authors:  E L Sampson; J D Warren; M N Rossor
Journal:  Postgrad Med J       Date:  2004-03       Impact factor: 2.401

3.  Reversible Encephalopathy due to Valproic Acid Induced Hyperammonemia in a Patient with Bipolar I Disorder: A Cautionary Report.

Authors:  Neel Patel; Katherine B Landry; Rachel E Fargason; Badari Birur
Journal:  Psychopharmacol Bull       Date:  2017-01-26

4.  Rapidly fatal hyperammonemic coma in adults. Urea cycle enzyme deficiency.

Authors:  B E Wilson; W N Hobbs; J J Newmark; S J Farrow
Journal:  West J Med       Date:  1994-08

5.  Specificity of PCR-SSCP for detection of the mutant ornithine transcarbamylase (OTC) gene in patients with OTC deficiency.

Authors:  R Hoshide; T Matsuura; S Komaki; E Koike; I Ueno; I Matsuda
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

6.  Prenatal monitoring of ornithine transcarbamoylase deficiency in two families by DNA analysis.

Authors:  T Matsuura; R Hoshide; M Fukushima; T Sakiyama; M Owada; I Matsuda
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

7.  Site specific screening for point mutations in ornithine transcarbamylase deficiency.

Authors:  D Feldmann; J M Rozet; A Pelet; D Hentzen; P Briand; P Hubert; C Largilliere; D Rabier; J P Farriaux; A Munnich
Journal:  J Med Genet       Date:  1992-07       Impact factor: 6.318

8.  Developing adenoviral-mediated in vivo gene therapy for ornithine transcarbamylase deficiency.

Authors:  S E Raper; J M Wilson; M Yudkoff; M B Robinson; X Ye; M L Batshaw
Journal:  J Inherit Metab Dis       Date:  1998       Impact factor: 4.982

9.  An insight into the biochemistry of inborn errors of metabolism for a clinical neurologist.

Authors:  Rita Christopher; Bindu P Sankaran
Journal:  Ann Indian Acad Neurol       Date:  2008-04       Impact factor: 1.383

10.  Valproic Acid-induced hyperammonemia in the elderly: a review of the literature.

Authors:  Vikrant Mittal; Sunanda Muralee; Rajesh R Tampi
Journal:  Case Rep Med       Date:  2009-08-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.